首页> 外文期刊>Vascular pharmacology >Potassium channels and erectile dysfunction.
【24h】

Potassium channels and erectile dysfunction.

机译:钾通道和勃起功能障碍。

获取原文
获取原文并翻译 | 示例
       

摘要

The incidence of erectile dysfunction (ED), defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance, increases with age and with risk factors for vascular disease, including smoking, diabetes and hypertension. Penile erection results from an arousal-induced synthesis of nitric oxide (NO) in nonadrenergic-noncholinergic nerves (NANC), endothelial cells and cavernosal smooth muscle cells (SMCs). Vasodilation and relaxation of cavernosal SMCs engorges the corpora cavernosa with blood at arterial pressure. The subcellular mechanism by which tumescence occurs involves NO-induced activation of soluble guanylate cyclase, increased cyclic guanosine monophosphate (cGMP) levels and activation of cGMP-dependent protein kinase (PKG). PKG phosphorylates numerous ion channels and pumps, each promoting a reduction in cytosolic calcium. In particular, PKG activates high-conductance Ca2+(-)sensitive K+ (BKCa) channels, which hyperpolarize the arterial and cavernosal SMC membranes, causing relaxation. This mechanism appears to be compromised with age and with vascular disease, leading to ED. Thus, increasing cavernosal nitric oxide synthase (NOS) expression, cGMP levels and/or BKCa channel expression is an effective therapy for experimental ED. Future therapies may involve augmenting K+ channel expression by gene transfer or increasing channel function through the use of Type 5 phosphodiesterase (Type 5 PDE) inhibitors or phosphatase inhibitors.
机译:勃起功能障碍(ED)的发生率定义为持续无法实现或维持足以使人满意的性行为的勃起,随着年龄的增长以及包括吸烟,糖尿病和高血压在内的血管疾病的危险因素而增加。阴茎勃起是由非肾上腺素能非胆碱能神经(NANC),内皮细胞和海绵体平滑肌细胞(SMCs)引起的一氧化氮(NO)的合成引起的。海绵体SMC的血管舒张和舒张使海绵体充满动脉压力的血液。发生肿胀的亚细胞机制涉及NO诱导的可溶性鸟苷酸环化酶激活,环状鸟苷单磷酸(cGMP)水平升高和cGMP依赖性蛋白激酶(PKG)激活。 PKG会磷酸化大量离子通道和泵,每个离子通道和泵都会促进胞质钙的减少。特别是,PKG激活高电导的Ca2 +(-)敏感的K +(BKCa)通道,从而使动脉和海绵体SMC膜超极化,从而引起松弛。该机制似乎随年龄和血管疾病而受损,从而导致ED。因此,增加海绵体一氧化氮合酶(NOS)表达,cGMP水平和/或BKCa通道表达是实验性ED的有效疗法。未来的治疗可能涉及通过使用5型磷酸二酯酶(5 PDE型)抑制剂或磷酸酶抑制剂通过基因转移增强K +通道表达或增加通道功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号